Global Home and Alternate Site Infusion Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 307507
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Home and Alternate Site Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Home and Alternate Site Infusion Therapy market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Residential accounting for % of the Home and Alternate Site Infusion Therapy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Home and Alternate Site Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, and McLaren, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Home and Alternate Site Infusion Therapy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Chemotherapy

Anti-infective Therapies

Immune Therapy

General Nursing Services

Others

Market segment by Application, can be divided into

Residential

Ambulatory Infusion Centers

Others

Market segment by players, this report covers

Option Care Health

Coram CVS

UnitedHealth Group

HCA Healthcare

McLaren

CHI Health

Accredo Health

PharMerica

Cleveland Clinic

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Home and Alternate Site Infusion Therapy product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Home and Alternate Site Infusion Therapy, with revenue, gross margin and global market share of Home and Alternate Site Infusion Therapy from 2019 to 2022.

Chapter 3, the Home and Alternate Site Infusion Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Home and Alternate Site Infusion Therapy market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Home and Alternate Site Infusion Therapy research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Home and Alternate Site Infusion Therapy

1.2 Classification of Home and Alternate Site Infusion Therapy by Type

1.2.1 Overview: Global Home and Alternate Site Infusion Therapy Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2021

1.2.3 Chemotherapy

1.2.4 Anti-infective Therapies

1.2.5 Immune Therapy

1.2.6 General Nursing Services

1.2.7 Others

1.3 Global Home and Alternate Site Infusion Therapy Market by Application

1.3.1 Overview: Global Home and Alternate Site Infusion Therapy Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Residential

1.3.3 Ambulatory Infusion Centers

1.3.4 Others

1.4 Global Home and Alternate Site Infusion Therapy Market Size & Forecast

1.5 Global Home and Alternate Site Infusion Therapy Market Size and Forecast by Region

1.5.1 Global Home and Alternate Site Infusion Therapy Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Home and Alternate Site Infusion Therapy Market Size by Region, (2017-2022)

1.5.3 North America Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)

1.5.4 Europe Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)

1.5.6 South America Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Home and Alternate Site Infusion Therapy Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Home and Alternate Site Infusion Therapy Market Drivers

1.6.2 Home and Alternate Site Infusion Therapy Market Restraints

1.6.3 Home and Alternate Site Infusion Therapy Trends Analysis

2 Company Profiles

2.1 Option Care Health

2.1.1 Option Care Health Details

2.1.2 Option Care Health Major Business

2.1.3 Option Care Health Home and Alternate Site Infusion Therapy Product and Solutions

2.1.4 Option Care Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Option Care Health Recent Developments and Future Plans

2.2 Coram CVS

2.2.1 Coram CVS Details

2.2.2 Coram CVS Major Business

2.2.3 Coram CVS Home and Alternate Site Infusion Therapy Product and Solutions

2.2.4 Coram CVS Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Coram CVS Recent Developments and Future Plans

2.3 UnitedHealth Group

2.3.1 UnitedHealth Group Details

2.3.2 UnitedHealth Group Major Business

2.3.3 UnitedHealth Group Home and Alternate Site Infusion Therapy Product and Solutions

2.3.4 UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 UnitedHealth Group Recent Developments and Future Plans

2.4 HCA Healthcare

2.4.1 HCA Healthcare Details

2.4.2 HCA Healthcare Major Business

2.4.3 HCA Healthcare Home and Alternate Site Infusion Therapy Product and Solutions

2.4.4 HCA Healthcare Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 HCA Healthcare Recent Developments and Future Plans

2.5 McLaren

2.5.1 McLaren Details

2.5.2 McLaren Major Business

2.5.3 McLaren Home and Alternate Site Infusion Therapy Product and Solutions

2.5.4 McLaren Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 McLaren Recent Developments and Future Plans

2.6 CHI Health

2.6.1 CHI Health Details

2.6.2 CHI Health Major Business

2.6.3 CHI Health Home and Alternate Site Infusion Therapy Product and Solutions

2.6.4 CHI Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 CHI Health Recent Developments and Future Plans

2.7 Accredo Health

2.7.1 Accredo Health Details

2.7.2 Accredo Health Major Business

2.7.3 Accredo Health Home and Alternate Site Infusion Therapy Product and Solutions

2.7.4 Accredo Health Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Accredo Health Recent Developments and Future Plans

2.8 PharMerica

2.8.1 PharMerica Details

2.8.2 PharMerica Major Business

2.8.3 PharMerica Home and Alternate Site Infusion Therapy Product and Solutions

2.8.4 PharMerica Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 PharMerica Recent Developments and Future Plans

2.9 Cleveland Clinic

2.9.1 Cleveland Clinic Details

2.9.2 Cleveland Clinic Major Business

2.9.3 Cleveland Clinic Home and Alternate Site Infusion Therapy Product and Solutions

2.9.4 Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Cleveland Clinic Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Home and Alternate Site Infusion Therapy Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Home and Alternate Site Infusion Therapy Players Market Share in 2021

3.2.2 Top 10 Home and Alternate Site Infusion Therapy Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Home and Alternate Site Infusion Therapy Players Head Office, Products and Services Provided

3.4 Home and Alternate Site Infusion Therapy Mergers & Acquisitions

3.5 Home and Alternate Site Infusion Therapy New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Home and Alternate Site Infusion Therapy Revenue and Market Share by Type (2017-2022)

4.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Application (2017-2022)

5.2 Global Home and Alternate Site Infusion Therapy Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)

6.2 North America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)

6.3 North America Home and Alternate Site Infusion Therapy Market Size by Country

6.3.1 North America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)

6.3.2 United States Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

6.3.3 Canada Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

6.3.4 Mexico Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)

7.2 Europe Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)

7.3 Europe Home and Alternate Site Infusion Therapy Market Size by Country

7.3.1 Europe Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)

7.3.2 Germany Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7.3.3 France Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7.3.5 Russia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

7.3.6 Italy Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)

8.2 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)

8.3 Asia-Pacific Home and Alternate Site Infusion Therapy Market Size by Region

8.3.1 Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2017-2028)

8.3.2 China Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8.3.3 Japan Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8.3.4 South Korea Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8.3.5 India Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

8.3.7 Australia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)

9.2 South America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)

9.3 South America Home and Alternate Site Infusion Therapy Market Size by Country

9.3.1 South America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)

9.3.2 Brazil Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

9.3.3 Argentina Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2017-2028)

10.2 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2017-2028)

10.3 Middle East & Africa Home and Alternate Site Infusion Therapy Market Size by Country

10.3.1 Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2017-2028)

10.3.2 Turkey Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

10.3.4 UAE Home and Alternate Site Infusion Therapy Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Home and Alternate Site Infusion Therapy Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Home and Alternate Site Infusion Therapy Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Home and Alternate Site Infusion Therapy Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Region (2017-2022)

Table 5. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2023-2028)

Table 6. Option Care Health Corporate Information, Head Office, and Major Competitors

Table 7. Option Care Health Major Business

Table 8. Option Care Health Home and Alternate Site Infusion Therapy Product and Solutions

Table 9. Option Care Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Coram CVS Corporate Information, Head Office, and Major Competitors

Table 11. Coram CVS Major Business

Table 12. Coram CVS Home and Alternate Site Infusion Therapy Product and Solutions

Table 13. Coram CVS Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. UnitedHealth Group Corporate Information, Head Office, and Major Competitors

Table 15. UnitedHealth Group Major Business

Table 16. UnitedHealth Group Home and Alternate Site Infusion Therapy Product and Solutions

Table 17. UnitedHealth Group Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. HCA Healthcare Corporate Information, Head Office, and Major Competitors

Table 19. HCA Healthcare Major Business

Table 20. HCA Healthcare Home and Alternate Site Infusion Therapy Product and Solutions

Table 21. HCA Healthcare Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. McLaren Corporate Information, Head Office, and Major Competitors

Table 23. McLaren Major Business

Table 24. McLaren Home and Alternate Site Infusion Therapy Product and Solutions

Table 25. McLaren Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. CHI Health Corporate Information, Head Office, and Major Competitors

Table 27. CHI Health Major Business

Table 28. CHI Health Home and Alternate Site Infusion Therapy Product and Solutions

Table 29. CHI Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Accredo Health Corporate Information, Head Office, and Major Competitors

Table 31. Accredo Health Major Business

Table 32. Accredo Health Home and Alternate Site Infusion Therapy Product and Solutions

Table 33. Accredo Health Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. PharMerica Corporate Information, Head Office, and Major Competitors

Table 35. PharMerica Major Business

Table 36. PharMerica Home and Alternate Site Infusion Therapy Product and Solutions

Table 37. PharMerica Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Cleveland Clinic Corporate Information, Head Office, and Major Competitors

Table 39. Cleveland Clinic Major Business

Table 40. Cleveland Clinic Home and Alternate Site Infusion Therapy Product and Solutions

Table 41. Cleveland Clinic Home and Alternate Site Infusion Therapy Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 43. Global Home and Alternate Site Infusion Therapy Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 44. Breakdown of Home and Alternate Site Infusion Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Home and Alternate Site Infusion Therapy Players Head Office, Products and Services Provided

Table 46. Home and Alternate Site Infusion Therapy Mergers & Acquisitions in the Past Five Years

Table 47. Home and Alternate Site Infusion Therapy New Entrants and Expansion Plans

Table 48. Global Home and Alternate Site Infusion Therapy Revenue (USD Million) by Type (2017-2022)

Table 49. Global Home and Alternate Site Infusion Therapy Revenue Share by Type (2017-2022)

Table 50. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Type (2023-2028)

Table 51. Global Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022)

Table 52. Global Home and Alternate Site Infusion Therapy Revenue Forecast by Application (2023-2028)

Table 53. North America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)

Table 54. North America Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)

Table 55. North America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)

Table 56. North America Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)

Table 57. North America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)

Table 58. North America Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)

Table 59. Europe Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)

Table 60. Europe Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)

Table 61. Europe Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)

Table 62. Europe Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)

Table 63. Europe Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)

Table 64. Europe Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)

Table 65. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)

Table 66. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)

Table 67. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)

Table 68. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)

Table 69. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2017-2022) & (USD Million)

Table 70. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue by Region (2023-2028) & (USD Million)

Table 71. South America Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)

Table 72. South America Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)

Table 73. South America Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)

Table 74. South America Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)

Table 75. South America Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)

Table 76. South America Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)

Table 77. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2017-2022) & (USD Million)

Table 78. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Type (2023-2028) & (USD Million)

Table 79. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2017-2022) & (USD Million)

Table 80. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Application (2023-2028) & (USD Million)

Table 81. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2017-2022) & (USD Million)

Table 82. Middle East & Africa Home and Alternate Site Infusion Therapy Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Home and Alternate Site Infusion Therapy Picture

Figure 2. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Type in 2021

Figure 3. Chemotherapy

Figure 4. Anti-infective Therapies

Figure 5. Immune Therapy

Figure 6. General Nursing Services

Figure 7. Others

Figure 8. Home and Alternate Site Infusion Therapy Revenue Market Share by Application in 2021

Figure 9. Residential Picture

Figure 10. Ambulatory Infusion Centers Picture

Figure 11. Others Picture

Figure 12. Global Home and Alternate Site Infusion Therapy Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Home and Alternate Site Infusion Therapy Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2017-2028)

Figure 15. Global Home and Alternate Site Infusion Therapy Revenue Market Share by Region in 2021

Figure 16. North America Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Home and Alternate Site Infusion Therapy Market Drivers

Figure 22. Home and Alternate Site Infusion Therapy Market Restraints

Figure 23. Home and Alternate Site Infusion Therapy Market Trends

Figure 24. Option Care Health Recent Developments and Future Plans

Figure 25. Coram CVS Recent Developments and Future Plans

Figure 26. UnitedHealth Group Recent Developments and Future Plans

Figure 27. HCA Healthcare Recent Developments and Future Plans

Figure 28. McLaren Recent Developments and Future Plans

Figure 29. CHI Health Recent Developments and Future Plans

Figure 30. Accredo Health Recent Developments and Future Plans

Figure 31. PharMerica Recent Developments and Future Plans

Figure 32. Cleveland Clinic Recent Developments and Future Plans

Figure 33. Global Home and Alternate Site Infusion Therapy Revenue Share by Players in 2021

Figure 34. Home and Alternate Site Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2021

Figure 36. Global Top 10 Players Home and Alternate Site Infusion Therapy Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Home and Alternate Site Infusion Therapy Revenue Share by Type in 2021

Figure 39. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Type (2023-2028)

Figure 40. Global Home and Alternate Site Infusion Therapy Revenue Share by Application in 2021

Figure 41. Global Home and Alternate Site Infusion Therapy Market Share Forecast by Application (2023-2028)

Figure 42. North America Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)

Figure 43. North America Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)

Figure 44. North America Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)

Figure 45. United States Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)

Figure 49. Europe Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)

Figure 50. Europe Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)

Figure 51. Germany Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Home and Alternate Site Infusion Therapy Revenue Market Share by Region (2017-2028)

Figure 59. China Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)

Figure 66. South America Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)

Figure 67. South America Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Home and Alternate Site Infusion Therapy Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Home and Alternate Site Infusion Therapy Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Home and Alternate Site Infusion Therapy Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Home and Alternate Site Infusion Therapy Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz